COMMONWEALTH BANK OF AUSTRALIA - WUXI PHARMATECH CAYMAN INC ownership

Quarter-by-quarter ownership
COMMONWEALTH BANK OF AUSTRALIA ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$32,911,000
-67.6%
761,636
-68.3%
0.42%
-69.0%
Q2 2015$101,674,000
-0.2%
2,405,916
-8.4%
1.35%
-1.7%
Q1 2015$101,836,000
+15.2%
2,625,9920.0%1.38%
+9.8%
Q4 2014$88,417,000
-3.9%
2,625,992
-0.0%
1.25%
+5.2%
Q3 2014$91,989,000
+6.6%
2,626,7490.0%1.19%
+2.5%
Q2 2014$86,315,000
-17.9%
2,626,749
-7.9%
1.16%
+72.9%
Q1 2014$105,131,000
-16.7%
2,852,180
-13.3%
0.67%
-22.4%
Q4 2013$126,258,000
+40.0%
3,289,695
-0.1%
0.87%
+32.4%
Q3 2013$90,213,000
+30.9%
3,292,437
+0.3%
0.65%
+26.0%
Q2 2013$68,918,0003,281,8330.52%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q3 2023
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,762,017$64,948,0007.10%
Coupland Cardiff Asset Management LLP 261,361$9,634,0006.70%
Sloane Robinson LLP 160,100$5,901,0003.50%
Myriad Asset Management Ltd. 418,728$15,434,0003.07%
Granite Point Capital Management, L.P. 102,000$3,760,0002.69%
GRATRY & Co LLC 191,545$7,060,0002.54%
Consonance Capital Management LP 430,889$15,883,0002.36%
Grandeur Peak Global Advisors, LLC 263,135$9,699,0002.29%
Mirae Asset Global Investments Co., Ltd. 2,356,378$86,856,0002.20%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 91,460$3,371,0001.60%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders